Total Payments
$12,475
2024 Payments
$1,312
Companies
58
Transactions
1,026
Medicare Patients
1,343
Medicare Billing
$114,312
Payment Breakdown by Category
Food & Beverage$12,119 (97.2%)
Education$355.03 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,119 | 1,014 | 97.2% |
| Education | $355.03 | 12 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,480 | 128 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,083 | 101 | $0 (2024) |
| PFIZER INC. | $1,031 | 127 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,027 | 58 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $840.25 | 63 | $0 (2023) |
| Amgen Inc. | $818.62 | 66 | $0 (2024) |
| ABBVIE INC. | $639.57 | 41 | $0 (2024) |
| Lilly USA, LLC | $591.07 | 47 | $0 (2024) |
| Merck Sharp & Dohme LLC | $556.41 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $502.29 | 35 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,312 | 77 | Novo Nordisk Inc ($316.85) |
| 2023 | $1,140 | 68 | PFIZER INC. ($169.90) |
| 2022 | $629.99 | 37 | ABBVIE INC. ($147.16) |
| 2021 | $394.00 | 25 | GlaxoSmithKline, LLC. ($54.47) |
| 2020 | $1,124 | 80 | Amgen Inc. ($199.65) |
| 2019 | $2,257 | 197 | Amgen Inc. ($244.79) |
| 2018 | $2,753 | 265 | Novo Nordisk Inc ($323.30) |
| 2017 | $2,864 | 277 | GlaxoSmithKline, LLC. ($357.66) |
All Payment Transactions
1,026 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Oncology | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Biological | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 174 | 348 | $36,453 | $17,643 |
| 2022 | 5 | 275 | 364 | $51,464 | $15,912 |
| 2021 | 6 | 407 | 668 | $111,256 | $40,657 |
| 2020 | 9 | 487 | 769 | $119,895 | $40,099 |
Total Patients
1,343
Total Services
2,149
Medicare Billing
$114,312
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 127 | $23,103 | $10,043 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 57 | $7,318 | $2,589 | 35.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 27 | 27 | $2,048 | $1,973 | 96.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 14 | 14 | $2,601 | $1,709 | 65.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $810.00 | $767.88 | 94.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 96 | $573.00 | $561.54 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 194 | $37,464 | $9,620 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 83 | $10,956 | $3,383 | 30.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 29 | 29 | $2,088 | $2,037 | 97.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $870.00 | $787.35 | 90.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 27 | 29 | $87.00 | $85.26 | 98.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 365 | $71,905 | $26,496 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 139 | $18,487 | $7,086 | 38.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 68 | 68 | $12,444 | $4,451 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 12 | 12 | $3,744 | $1,510 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 67 | 67 | $4,489 | $1,055 | 23.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 14 | 17 | $187.00 | $59.16 | 31.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 163 | 376 | $74,072 | $22,304 | 30.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 91 | 134 | $17,822 | $5,498 | 30.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 66 | 66 | $6,138 | $3,903 | 63.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $7,800 | $2,778 | 35.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 23 | 23 | $3,956 | $2,510 | 63.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 28 | $3,780 | $1,652 | 43.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 68 | 68 | $4,556 | $1,038 | 22.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 22 | 22 | $1,474 | $330.02 | 22.4% |
About Dr. Christopher Thompson, MD
Dr. Christopher Thompson, MD is a Family Medicine healthcare provider based in Smyrna, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194710889.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Thompson, MD has received a total of $12,475 in payments from pharmaceutical and medical device companies, with $1,312 received in 2024. These payments were reported across 1,026 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($12,119).
As a Medicare-enrolled provider, Thompson has provided services to 1,343 Medicare beneficiaries, totaling 2,149 services with total Medicare billing of $114,312. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Smyrna, TN
- Active Since 09/19/2005
- Last Updated 08/18/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1194710889
Products in Payments
- FARXIGA (Drug) $659.72
- Ozempic (Drug) $627.85
- ENTRESTO (Drug) $427.60
- TRELEGY ELLIPTA (Drug) $398.16
- CHANTIX (Drug) $377.72
- JANUVIA (Drug) $370.88
- XARELTO (Drug) $368.76
- JARDIANCE (Drug) $343.52
- SOLIQUA (Drug) $339.20
- Aimovig (Biological) $317.96
- Victoza (Drug) $313.21
- MOUNJARO (Drug) $280.05
- ANORO (Drug) $277.75
- VRAYLAR (Drug) $268.97
- BREO (Drug) $250.08
- ELIQUIS (Drug) $248.35
- UBRELVY (Drug) $224.25
- Kerendia (Drug) $213.24
- SYMBICORT (Drug) $208.73
- Prolia (Biological) $202.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Smyrna
Joshua Hixson, M.d, M.D
Family Medicine — Payments: $21,983
Family Medicine $21,983
Dr. Kirsten Bunce, Md, MD
Family Medicine — Payments: $17,877
Family Medicine $17,877
Mr. Bryan Kozinski, Md, MD
Family Medicine — Payments: $13,808
Family Medicine $13,808
Mr. Peter Cobb, Md, MD
Family Medicine — Payments: $13,293
Family Medicine $13,293
Dr. David Kim, M.d, M.D
Family Medicine — Payments: $8,126
Family Medicine $8,126
A Chervenak, D.o, D.O
Family Medicine — Payments: $6,527
Family Medicine $6,527